Recruiting PHASE3 INTERVENTIONAL 2-arm NCT06241612

Individualized Elective Neck Irradiation in NPC Patients

Individualized Elective Neck Irradiation Based on the Lymph Node Metastasis Pattern in NPC Patients

Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

Interventions Individualized Elective Neck Irradiation

Updated 5 times since 2024 Last updated: Sep 10, 2025 Started: Apr 16, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2031

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Nasopharyngeal Carcinoma, this trial is actively recruiting participants. The trial is conducted by Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center and has accumulated 5 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Oct 2025 — Present [monthly]

Recruiting PHASE3
Sep 2024 — Oct 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
May 2024 — Jul 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Mar 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Eye & ENT Hospital of Fudan University
First Affiliated Hospital of Guangxi Medical University
First Hospital of China Medical University
First People's Hospital of Foshan
Qingyuan People's Hospital
Renmin Hospital of Wuhan University
Sichuan Cancer Hospital and Research Institute
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Xiangya Hospital of Central South University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China